CLASS II Device recall · Reported 28 Nov 2018 · FDA Enforcement Report

Tosoh AIA-900 immunoassay Analyzer recalled by Tosoh Bioscience

Tosoh Bioscience is recalling Tosoh AIA-900 immunoassay Analyzer, distributed in Georgia, New York. The recall was initiated on 28 Sep 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codes10313605 10503612 10634103
Quantity recalled3

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0485-2019
FDA event ID
81219
Recalling firm
Tosoh Bioscience, Grove City, OH
Classification
Class II
Status
Terminated
Recall initiated
28 Sep 2018
FDA classified
19 Nov 2018
Reported
28 Nov 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

28 Sep 2018Recall initiated by company
19 Nov 2018Classified by FDA+52 days
28 Nov 2018Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

A software issue may cause the liquid volume detection entries for 2nd and 3rd reagent bottles to be overwritten with the data from the 1st reagent bottle. Tosoh has released software version 2.51 (or later) to fix the problem. This failure is mitigated by the hardware design. The consequence would be a slight delay in testing patient sample or reporting patient result.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Tosoh AIA-900 immunoassay Analyzer

Where it was distributed

Distributed to accounts in GA and NY.

GeorgiaNew York

Questions about this recall

Why was it recalled?

A software issue may cause the liquid volume detection entries for 2nd and 3rd reagent bottles to be overwritten with the data from the 1st reagent bottle. Tosoh has released software version 2.51 (or later) to fix the problem. This failure is mitigated by the hardware design. The consequence would be a slight delay in testing patient sample or reporting patient result.

Which lots are affected?

10313605 10503612 10634103

Where was it sold?

Distributed to accounts in GA and NY.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Tosoh Bioscience

All 74

Other Test Kits & Diagnostics recalls

All 2,671